Great piece! It isn't that Gd is poisonous, it's the fact that you should only accept it if there is no other way. The fact remains that we have 'another way' and that needs to be refined and made more available. Oooops! There's the rub, it's going to cost money and imaging centers already have significant investments in 'the other way'. <sigh>
High-quality, level-1 evidence (2025 multicenter noninferiority trial) shows biparametric MRI (no gadolinium) is noninferior to full multiparametric MRI for detecting clinically significant PCa in biopsy-naïve men—opening a path to skip contrast when image quality is adequate. This aligns with 2024 data trending the same way. (ChatGPT)
Great piece! It isn't that Gd is poisonous, it's the fact that you should only accept it if there is no other way. The fact remains that we have 'another way' and that needs to be refined and made more available. Oooops! There's the rub, it's going to cost money and imaging centers already have significant investments in 'the other way'. <sigh>
So if gadolinium has been used, what happens to it afterwards? Does it accumulate? Is it purged, maybe by the kidneys or liver?
In the short term, it can cause allergic reactions and potentially damage the kidneys in some patients. Long-term, it can accumulate in the brain, and the doctors say the long-term effects are unknown. Note: I'm not a doctor, but a medical journalist. Back in 2019, I wrote more about GAD: https://ziniy.com/chicago-medicine-magazine/october-2019 More here: https://www.medpagetoday.com/special-reports/apatientsjourney/81259 This has been a major concern by patients.
High-quality, level-1 evidence (2025 multicenter noninferiority trial) shows biparametric MRI (no gadolinium) is noninferior to full multiparametric MRI for detecting clinically significant PCa in biopsy-naïve men—opening a path to skip contrast when image quality is adequate. This aligns with 2024 data trending the same way. (ChatGPT)
Thank you.